Keros Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Keros Therapeutics, Inc. (KROS) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$15.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-03
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $497.00K, a 90.25% decline year-over-year.
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$15.67M.
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$141.00K, a 102.69% decline year-over-year.
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$4.43M.
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$4.02M, a 139.33% decline from fiscal 2024.
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $10.22M, a 10.05% increase from fiscal 2023.
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $9.28M, a 179.55% increase from fiscal 2022.
- Keros Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.32M, a 114.53% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $497.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$15.18M 10-Q · filed 2026-08-03 | -$15.32M derived: sum of 3 quarters · filed 2026-08-03 | -$19.75M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$15.67M 10-Q · filed 2026-05-14 | -$15.81M derived: sum of 2 quarters · filed 2026-05-14 | -$20.25M derived: sum of 3 quarters · filed 2026-05-14 | -$15.15M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$4.58M derived: sum of 2 quarters · filed 2026-03-04 | $525.00K derived: sum of 3 quarters · filed 2026-08-03 | -$4.02M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $666.00K derived: sum of 2 quarters · filed 2026-08-03 | -$3.88M 10-Q · filed 2025-11-05 | $1.37M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $5.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $557.00K 10-Q · filed 2026-08-03 | $5.80M derived: sum of 3 quarters · filed 2026-08-03 | -$70.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$4.54M 10-Q · filed 2026-05-14 | $703.00K derived: sum of 2 quarters · filed 2026-05-14 | -$5.17M derived: sum of 3 quarters · filed 2026-05-14 | $1.20M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $5.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$627.00K derived: sum of 2 quarters · filed 2026-03-04 | $5.74M derived: sum of 3 quarters · filed 2026-03-04 | $10.22M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$5.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $493.00K derived: sum of 2 quarters · filed 2025-11-05 | $4.97M 10-Q · filed 2025-11-05 | $4.43M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $6.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.84M 10-Q · filed 2025-08-06 | $10.30M derived: sum of 3 quarters · filed 2025-08-06 | $14.56M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $4.48M 10-Q · filed 2025-05-06 | $3.94M derived: sum of 2 quarters · filed 2025-05-06 | $8.20M derived: sum of 3 quarters · filed 2025-05-06 | $9.69M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$539.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.72M derived: sum of 2 quarters · filed 2025-02-26 | $5.21M derived: sum of 3 quarters · filed 2025-02-26 | $9.28M 10-K · filed 2025-02-26 |
| 2023-09-30 | $4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $5.75M derived: sum of 2 quarters · filed 2024-11-06 | $9.82M 10-Q · filed 2024-11-06 | $10.09M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.56M 10-Q · filed 2024-08-07 | $5.83M derived: sum of 3 quarters · filed 2025-02-26 | $5.55M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $4.07M 10-Q · filed 2024-05-08 | $4.34M derived: sum of 2 quarters · filed 2025-02-26 | $4.06M derived: sum of 3 quarters · filed 2025-02-26 | $8.16M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$17.00K derived: sum of 2 quarters · filed 2025-02-26 | $4.08M derived: sum of 3 quarters · filed 2025-02-26 | $3.32M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $3.81M derived: sum of 2 quarters · filed 2023-11-06 | $3.05M 10-Q · filed 2023-11-06 | $1.72M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $4.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $3.34M 10-Q · filed 2023-08-07 | $2.01M derived: sum of 3 quarters · filed 2024-02-28 | $2.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$764.00K 10-Q · filed 2023-05-04 | -$2.09M derived: sum of 2 quarters · filed 2024-02-28 | -$1.57M derived: sum of 3 quarters · filed 2024-02-28 | $1.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$806.00K derived: sum of 2 quarters · filed 2024-02-28 | $2.62M derived: sum of 3 quarters · filed 2024-02-28 | $1.55M 10-K · filed 2024-02-28 |
| 2021-09-30 | $521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $3.95M derived: sum of 2 quarters · filed 2022-11-03 | $2.88M 10-Q · filed 2022-11-03 | $2.12M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.35M 10-Q · filed 2022-08-04 | $1.60M derived: sum of 3 quarters · filed 2022-08-04 | $374.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$1.07M 10-Q · filed 2022-05-05 | -$1.83M derived: sum of 2 quarters · filed 2022-05-05 | -$3.05M derived: sum of 3 quarters · filed 2022-05-05 | -$418.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | -$1.98M derived: sum of 2 quarters · filed 2022-03-09 | $653.00K derived: sum of 3 quarters · filed 2022-03-09 | $1.47M 10-K · filed 2022-03-09 |
| 2020-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.41M derived: sum of 2 quarters · filed 2021-11-04 | $2.23M 10-Q · filed 2021-11-04 | $2.19M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.45M 10-Q · filed 2021-08-05 | $3.42M derived: sum of 3 quarters · filed 2021-08-05 | $3.41M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $816.00K 10-Q · filed 2021-05-06 | $785.00K derived: sum of 2 quarters · filed 2021-05-06 | $778.00K derived: sum of 3 quarters · filed 2021-05-06 | $640.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$38.00K derived: sum of 2 quarters · filed 2021-03-25 | -$176.00K derived: sum of 3 quarters · filed 2021-03-25 | -$1.89M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$145.00K derived: sum of 2 quarters · filed 2020-11-10 | -$1.86M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$1.85M 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$1.72M 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |